{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "8004292", "DateCompleted": {"Year": "1994", "Month": "07", "Day": "15"}, "DateRevised": {"Year": "2015", "Month": "11", "Day": "19"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1073-449X", "JournalIssue": {"Volume": "149", "Issue": "6", "PubDate": {"Year": "1994", "Month": "Jun"}}, "Title": "American journal of respiratory and critical care medicine", "ISOAbbreviation": "Am J Respir Crit Care Med"}, "ArticleTitle": "Pre-exposure to ozone does not enhance or produce exercise-induced asthma.", "Pagination": {"StartPage": "1413", "EndPage": "1419", "MedlinePgn": "1413-9"}, "Abstract": {"AbstractText": ["We evaluated whether acute exposure to ozone (O3) enhances or produces exercise-induced asthma (EIA) in asthmatic subjects who have or do not have EIA, according to standardized exercise challenge. Twenty-one otherwise healthy asthmatic subjects, 19 to 40 yr of age, with forced expiratory volume in one second (FEV1) greater than 70% of predicted and methacholine hyperresponsiveness, underwent three 1-h exposures on separate days to 0.10 ppm ozone in filtered air (FA), 0.25 ppm ozone in FA, and FA alone (randomized order, single-blinded, crossover design). Of these subjects, 12 underwent an additional exposure to 0.40 ppm ozone in FA. The subjects performed intermittent light exercise (with mean ventilation of 27 L/min) while in an environmentally controlled chamber (21 degrees C and 40% relative humidity). After each exposure, the subjects rested 1 h in clean air and performed serial postexposure spirometry. The subjects then underwent a standardized exercise challenge in clean air, followed by serial spirometry for 60 min. No significant changes in FEV1 or forced vital capacity (FVC) were found following 1-h exposures to 0, 0.10, and 0.25 ppm ozone (regardless of EIA status). The 12 subjects who underwent all four exposures showed a significant excess reduction in FEV1 (-0.35 +/- 0.37 L or -9.6%) after 1-h exposure to 0.40 ppm O3 (p = 0.017), regardless of EIA status. Postexposure FEV1 returned to baseline levels within 1 h. Postexposure changes in FVC showed similar magnitude and time course but were not statistically significant across exposure conditions or EIA status.(ABSTRACT TRUNCATED AT 250 WORDS)"]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, UCLA Medical Center."}], "Identifier": [], "LastName": "Weymer", "ForeName": "A R", "Initials": "AR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gong", "ForeName": "H", "Initials": "H", "Suffix": "Jr"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lyness", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Linn", "ForeName": "W S", "Initials": "WS"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Respir Crit Care Med", "NlmUniqueID": "9421642", "ISSNLinking": "1073-449X"}, "ChemicalList": [{"RegistryNumber": "0W5ETF9M2K", "NameOfSubstance": "Methacholine Chloride"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["chemically induced", "diagnosis", "physiopathology"], "DescriptorName": "Asthma, Exercise-Induced"}, {"QualifierName": [], "DescriptorName": "Bronchial Provocation Tests"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Exercise Test"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Forced Expiratory Volume"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Methacholine Chloride"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Severity of Illness Index"}, {"QualifierName": [], "DescriptorName": "Single-Blind Method"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": [], "DescriptorName": "Vital Capacity"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1994", "Month": "6", "Day": "1"}, {"Year": "2001", "Month": "3", "Day": "28", "Hour": "10", "Minute": "1"}, {"Year": "1994", "Month": "6", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8004292", "10.1164/ajrccm.149.6.8004292"]}}], "PubmedBookArticle": []}